V. Bettoli, S. Zauli, A. Borghi, G. Toni, S. Minghetti et al., Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativaacne inversa: a prospective study on 23 patients, J Eur Acad Dermatol Venereol, vol.28, pp.125-131, 2014.

J. Boer and E. F. Weltevreden, Hidradenitis suppurativa or acne inversa. A clinicopathological study of early lesions, Br J Dermatol, vol.135, pp.721-726, 1996.

J. W. Costerton, P. S. Stewart, and E. P. Greenberg, Bacterial biofilms: a common cause of persistent infections, Science, vol.284, issue.5418, pp.1318-1340, 1999.

M. Delage, H. Guet-revillet, S. Duchatelet, A. Hovnanian, X. Nassif et al., Deciphering the microbiology of hidradenitis suppurativa: a step forward towards understanding an enigmatic inflammatory skin disease, Exp Dermatol, vol.24, pp.736-743, 2015.

H. C. Flemming, J. Wingender, U. Szewzyk, P. Steinberg, S. A. Rice et al., Biofilms: an emergent form of bacterial life, Nat Rev Microbiol, vol.14, pp.563-75, 2016.

J. W. Frew, D. A. Vekic, J. Woods, and G. D. Cains, A systematic review and critical evaluation of reported pathogenic sequence variants in hidradenitis suppurativa, Br J Dermatol, vol.177, pp.987-98, 2017.

G. Gener, F. Canoui-poitrine, J. E. Revuz, F. O. Poli, F. Gabison et al., Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients, Dermatology, vol.219, pp.148-54, 2009.

P. C. Goldsmith and P. M. Dowd, Successful therapy of the follicular occlusion triad in a young woman with high dose oral antiandrogens and minocycline, J R Soc Med, vol.86, pp.729-759, 1993.

H. Guet-revillet, H. Coignard-biehler, J. P. Jais, G. Quesne, E. Frapy et al., Bacterial pathogens associated with hidradenitis suppurativa, Emerg Infect Dis, vol.20, 2014.

H. Guet-revillet, J. P. Jais, M. N. Ungeheuer, H. Coignard-biehler, S. Duchatelet et al., The microbiological landscape of anaerobic infections in hidradenitis suppurativa: a prospective metagenomic study, Clin Infect Dis, vol.65, pp.282-91, 2017.

L. K. Hoffman, M. H. Ghias, and M. A. Lowes, Pathophysiology of hidradenitis suppurativa, Semin Cutan Med Surg, vol.36, pp.47-54, 2017.

G. B. Jemec and P. Wendelboe, Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa, J Am Acad Dermatol, vol.39, pp.971-975, 1998.

O. Join-lambert, H. Coignard, J. P. Jais, H. Guet-revillet, S. Poiree et al., Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa, Dermatology, vol.222, pp.49-58, 2011.

O. Join-lambert, H. Coignard-biehler, J. P. Jais, M. Delage, H. Guet-revillet et al., Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients, J Antimicrob Chemother, vol.71, pp.513-533, 2016.

M. Knobel, E. A. O'toole, and F. J. Smith, Keratins and skin disease, Cell Tissue Res, vol.360, pp.583-592, 2015.

C. O. Mendonca and C. E. Griffiths, Clindamycin and rifampicin combination therapy for hidradenitis suppurativa, Br J Dermatol, vol.154, pp.977-985, 2006.

A. Negroni, M. Pierdomenico, S. Cucchiara, and L. Stronati, NOD2 and inflammation: current insights, J Inflamm Res, vol.11, pp.49-60, 2018.

G. Nikolakis, O. Join-lambert, I. Karagiannidis, H. Guet-revillet, C. C. Zouboulis et al., Bacteriology of hidradenitis suppurativa/acne inversa: a review, J Am Acad Dermatol, vol.73, issue.5, pp.12-20, 2015.

Y. J. Park and H. K. Lee, The role of skin and orogenital microbiota in protective immunity and chronic immune-mediated inflammatory disease, Front Immunol, vol.8, 1955.

H. C. Ring, R. Mikkelsen, P. Miller, I. M. Jenssen, H. Fuursted et al., The bacteriology of hidradenitis suppurativa: a systematic review, Exp Dermatol, vol.24, pp.727-758, 2015.

P. D. Shenefelt, Pyoderma gangrenosum associated with cystic acne and hidradenitis suppurativa controlled by adding minocycline and sulfasalazine to the treatment regimen, Cutis, vol.57, pp.315-324, 1996.

P. Theut-riis, J. Boer, E. P. Prens, D. M. Saunte, I. E. Deckers et al., Intralesional triamcinolone for flares of hidradenitis suppurativa (HS): a case series, J Am Acad Dermatol, vol.75, pp.1151-1156, 2016.

P. Theut-riis, L. R. Thorlacius, and G. B. Jemec, Investigational drugs in clinical trials for hidradenitis suppurativa, Expert Opin Investig Drugs, vol.27, pp.43-53, 2018.

H. H. Van-der-zee, J. Boer, E. P. Prens, and G. B. Jemec, The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa, Dermatology, vol.219, pp.143-150, 2009.

H. H. Van-der-zee, L. De-ruiter, J. Boer, D. G. Van-den-broecke, J. C. Hollander et al., Alterations in leucocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesions, Br J Dermatol, vol.166, pp.98-106, 2012.